Comparison
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858 vs 16p12 2 Microdeletion Syndrome C4708497
Clinical comparison between 21 Hydroxylase Deficient Congenital Adrenal Hyperplasia and 16p12 2 Microdeletion Syndrome for differential diagnosis and treatment planning.
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
An inherited disorder affecting adrenal hormone production, causing cortisol deficiency and other hormonal imbalances. Features may include ambiguous genitalia, salt-wasting crises, and growth issues. Treated with lifelong hormone replacement therapy.
16p12 2 Microdeletion Syndrome C4708497
A rare genetic condition where a small piece of chromosome 16 is missing. It can cause developmental delays, intellectual disability, and recurrent infections in some individuals. Treatment involves supportive therapies and medical management of symptoms.
6 comparison axes
Onset
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
0-null
16p12 2 Microdeletion Syndrome C4708497
0-5
Onset patterns differ
Severity
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
severe
16p12 2 Microdeletion Syndrome C4708497
moderate
Different severity levels
Chronic
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
Chronic
16p12 2 Microdeletion Syndrome C4708497
Chronic
Differing course
Communicable
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
No
16p12 2 Microdeletion Syndrome C4708497
No
Different transmission
Body System
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
endocrine
16p12 2 Microdeletion Syndrome C4708497
congenital
Same/different system
Category
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
endocrine
16p12 2 Microdeletion Syndrome C4708497
genetic
Different category
Bottom line
21-hydroxylase-deficient-congenital-adrenal-hyperplasia-C2936858 and 16p12-2-microdeletion-syndrome-C4708497 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858 | 16p12 2 Microdeletion Syndrome C4708497 | Discriminating power |
|---|---|---|---|
| Main presentation | Cortisol deficiency with possible salt-wasting crisis or atypical genitalia | Developmental delay, intellectual disability, or recurrent infections in some people | High |
| Hormone pattern | Adrenal hormone imbalance; crisis may involve low sodium and high potassium | No characteristic adrenal hormone pattern is established by the supplied data | High |
| Neurodevelopment | Not defined as a chromosomal microdeletion syndrome | Developmental delay or intellectual disability may be present | Moderate |
When to favor each condition
Choose 21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858 when
Newborn with atypical genitalia or suspected salt-wasting
This pattern fits an adrenal steroid disorder needing urgent endocrine assessment
High
Abnormal newborn screen suggesting 21-hydroxylase deficiency
Screening points toward CAH rather than a 16p12.2 deletion
High
Planning long-term adrenal hormone replacement
Lifelong replacement is the described treatment approach; doses are not specified here
Moderate
Choose 16p12 2 Microdeletion Syndrome C4708497 when
Developmental delay with a detected 16p12.2 deletion
The condition is defined by missing chromosomal material, confirmed genetically
High
Recurrent infections plus learning concerns without adrenal crisis
This combination better matches the described microdeletion features
Moderate
Counseling about a chromosome 16 copy-number variant
Care is supportive and symptom-based rather than hormone replacement
Moderate
How key tests differ
| Test | 21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858 | 16p12 2 Microdeletion Syndrome C4708497 | Interpretation |
|---|---|---|---|
| 17-hydroxyprogesterone or newborn CAH screen | May be abnormal and needs confirmatory endocrine and genetic testing | Not a diagnostic test for this deletion; no specific result is established | An abnormal screen suggests CAH but is not a complete diagnosis |
| Electrolytes and cortisol assessment | Crisis may show low sodium, high potassium, and low cortisol; cutoffs are not given | No characteristic electrolyte pattern is established | Results need clinician interpretation and cannot alone prove either condition |
| Genetic or chromosomal testing | Testing relevant to 21-hydroxylase deficiency, not a 16p12.2 deletion | Microarray or equivalent testing shows a 16p12.2 microdeletion | The method should match the suspected disorder |
Prognosis comparison
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
- Outcome
- Chronic condition whose course depends on crisis prevention and hormone management. Exact mortality is not established here.
- Factors
- Salt-wasting, early recognition, treatment adherence, and associated hormone imbalance
16p12 2 Microdeletion Syndrome C4708497
- Outcome
- Chronic and variable; developmental and medical support may be ongoing. Exact prognosis is not established.
- Factors
- Degree of developmental disability, infections, associated findings, and access to services
Time frame: Both are long-term. CAH can present in infancy; deletion-related concerns are often recognized in early childhood.
Severity labels differ, but individual outcomes vary and are not fully defined by these descriptions.
Complications comparison
| Complication | Presentation |
|---|---|
| Salt-wasting adrenal crisis | Can become life-threatening without urgent care Not a described feature Vomiting, dehydration, or shock in suspected CAH needs emergency evaluation |
| Growth and puberty | Growth issues may occur and warrant endocrine follow-up A specific growth effect is not established in the supplied description Do not assume the same growth complication in both conditions |
| Infection and development | Recurrent infection is not the defining feature Recurrent infections and developmental disability may occur in some Supportive care should be individualized |
Patient education highlights
- HighEmergency warning signs
For suspected CAH, seek urgent care for vomiting, dehydration, lethargy, or shock. Do not delay.
- HighMeaning of test results
An abnormal hormone result or a deletion finding needs specialist confirmation and clinical correlation.
- MediumDifferent care plans
CAH uses lifelong hormone replacement; microdeletion care centers on therapies and symptom management.